Media
Media Inquiries: media@alzpath.bio or 1-844-723-7228
ALZpath News
Clinical Trials on Alzheimer Disease (CTAD)
DECEMBER 27, 2022
Plasma P-tau217 Picks up Plaques, Tangles, Future Decline
Press Release
NOVEMBER 11, 2022
“ALZpath, Inc.”, an Alzheimer’s Disease Diagnostics and Patient Services Company Announces Novel Validated an Scalable Assay for Detection of Phosphorylated Tau 217 in Blood
Alzheimer’s in the News
Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease
Lilly Investors News Release: May 3, 2023
Catalyst: Hope is on the Horizon for Alzheimer’s Treatments
The Stanford GSB Experience: March 10, 2023
MIND and Mediterranean Diets Associated with fewer Alzheimer's Plaques and Tangles
American Academy of Neurology: March 8, 2023
